Results

Total Results: 564 records

Showing results for "anxiety".

241. AHRQ Slide Template-Widescreen
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-child-adolesc-mental-health-grand-rounds.pptx
     May 22, 2025 - prevalence of mental health conditions among children and adolescents, including the increase in rates of anxiety … Obsessive–Compulsive Scale (TOCS), Obsessive Compulsive Inventory-Child Self Report (CHOCI), and Spence Children's Anxiety … Certainly, the evidence on pharmacotherapy for comorbid conditions has been summarized such as anxiety

242. Implementation of Recommended Screening and Counseling Interventions to Prevent Mental Health Disorders in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-protocol.pdf
     October 01, 2023 - children and adolescents is increasing,2, 3 with the number of children and adolescents diagnosed with anxiety … Suicide Risk Screening • USPSTF (including interventions with insufficient evidence) − Screening for Anxiety

243. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-protocol-amendment.pdf
     February 05, 2025 - children and adolescents is increasing,2, 3 with the number of children and adolescents diagnosed with anxiety … Suicide Risk Screening • USPSTF (including interventions with insufficient evidence) − Screening for Anxiety

244. Binge-Eating Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
     December 01, 2015 - obese, have diabetes, or both) and mood regulation (e.g., in patients with coexisting depression or anxiety … other indexes of metabolic health—e.g., diabetes); and (4) general psychopathology (e.g., depression, anxiety … Weight and shape concerns, restraint, hunger, disinhibition • Depression disorder and symptoms • Anxiety … Weight and shape concerns, restraint, hunger, disinhibition • Depression disorder and symptoms • Anxiety … untreated, the condition may lead to or worsen other mental health concerns (e.g., depression or anxiety

245. Transparency of Reporting Requirements: Effectiveness of Treatments Options for the Prevention of Complications and Treatment of Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
     September 01, 2016 - Perinatal exposure to di-(2-ethylhexyl) phthalate affects anxiety- and depression-like behaviors in

246. Diagnosis and Treatment of Clinical Alzheimer's-type Dementia (CATD) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
     November 02, 2018 - and/or severity of patient BPSD* on validated tests Agitation/ aggression Psychosis Depression Anxiety … mirtazapine Anti-seizure/mood stabilizer e.g., Valproate, gabapentin, carbamazepine, lamotrigine Anti-anxiety … , benzodiazepine e.g., Clonazepam, diazepam, lorazepam, temazepam, alprazolam Anti-anxiety, other Buspirone … comparison, and then by targeted treatment outcome (agitation/aggression, psychosis, depression, anxiety … Revised Protocol Rationale Table 1 Caregiver harms for BPSD drug treatments listed as depression, anxiety

247. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - by the drug’s unpredictable psychiatric side effects in some patients, including hallucinations, anxiety … have noted some severe adverse events, including delayed-onset suicidal ideation, dysphoria, and anxiety … Depress Anxiety. 2014 Apr;31(4):335-43. Also available: http://dx.doi.org/10.1002/da.22253. … Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care … Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in

248. Alcohol-Misuse Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
     April 28, 2010 - cancer, neuropathy, cardiomyopathy, anemia, osteoporosis, cognitive impairment, depression, insomnia, anxiety … Moderate Anxiety No difference between groups (unable to calculate effect size). … limited evidence reporting no difference between intervention and control groups for smoking rates and anxiety … Germany found that brief interventions did not significantly reduce drinking for subjects with comorbid anxiety … alcohol interventions for general practice patients with problematic drinking behavior and comorbid anxiety

249. Making Healthcare Safer IV Rapid Review: Prevention in Adults of Infection With Transmission of Multidrug-Resistant Organisms (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-rapid-research.pdf
     April 01, 2024 - and unintended outcomes such as less patient-to-healthcare worker contact, increased depression, and anxiety … • A meta-analysis found more anxiety and depression in patients who were in infectious isolation … The synthesis was both meta-analytic for the outcome of anxiety and depression, and narrative for all … Eight studies reporting anxiety outcomes that were pooled using a random effects model yielded a standardized … mean difference of 1.45 (95% CI 0.56, 2.34) favoring higher anxiety when isolated.

250. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
     February 01, 2019 - (3) Existing Evidence and Treatment Modalities (4) Registries† (5) Other Related Work Anxiety … (http://www.ichom.org/medical- conditions/depression-anxiety/) ACORN – a collaborative research network … http://www.ichom.org/medical-conditions/depression-anxiety/) http://www.ichom.org/medical-conditions/ … depression-anxiety/) https://psychoutcomes.org/COMMONS/ACORNHistory) https://psychoutcomes.org/COMMONS … “depressive symptoms” to “Levels of Glutamate in Basal Ganglia Anxiety and Depression Association

251. App-D-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
     September 30, 2015 - 1.96 to 2.65, p<0.001 Depression: 2485/22097 vs. 6174/152194; aIRR 2.46, 95% CI 2.05 to 2.96, p<0.001 Anxiety … insurance and prescription drug coverage), geographic region, need factors (comorbidities, depression, and anxiety

252. Systematic Review Update: Noninvasive Nonpharmacologic Treatment for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
     December 11, 2018 - Harms and adverse effects o Secondary outcomes  Psychological distress (including depression and anxiety … interference  Pain Secondary Outcomes  Psychological distress (including depression, anxiety … Adverse effects Secondary outcomes • Psychological distress (including measures of depression and anxiety

253. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - positively affects social interaction, possibly promoting affiliative (group bonding) behaviors, reducing anxiety … A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social … anxiety disorder.

254. Mixed MethodsReview -Integrating Palliative Care with Chronic Disease Management in Ambulatory Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
     November 21, 2019 - Patient or caregiver health-related quality of life  Patient or caregiver symptoms of depression or anxiety … Patient or caregiver health-related quality of life  Patient or caregiver symptoms of depression, anxiety … Implementation of a collaborative care model for the treatment of depression and anxiety in a community

255. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
     August 08, 2017 - reduction): RD 0.10 (0.08 to 0.12) Function/disability: -0.21 (-0.26 to -0.16) QoL: -0.20 (-0.25 to -0.15) Anxiety … reduction): RD 0.10 (0.07 to 0.13) Function/disability: -0.16 (-0.22 to -0.10) QoL: -0.19 (-0.25 to -0.12) Anxiety … reduction): 0.11 (0.07 to 0.15) Function/disability: -0.29 (-0.37 to -0.21) QoL: -0.22 (-0.30 to -0.13) Anxiety

256. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
     February 10, 2010 - implementation (e.g., trainer experience) and/or nonbreathing components of the intervention (e.g., anxiety … implementation (e.g., trainer experience) and/or nonbreathing components of the intervention (e.g., anxiety

257. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
     February 01, 2019 - Psychological and social effects are also common and can manifest in a number of ways, including depression, anxiety … overall function or disability, and quality of life • Secondary outcomes will include depression, anxiety

258. Adverse Effects of First-Line Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
     February 07, 2018 - and comorbid seizures 2) patients with MDD and comorbid psychiatric conditions with the exception of anxiety … or patients with comorbid seizure disorder or comorbid psychiatric conditions with exception of anxiety

259. Observed Association Between Antidepressant Use and Pneumonia Risk Was Confounded by Comorbidity Measures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
     May 01, 2008 - diagnoses ever in past anterior horn motor neuron disease 30 (0.3) 20 (0.04) 7.29 (3.95 to 13.47) anxiety … to 1.97)) diagnoses ever in past anterior horn motor neuron disease 4 (2.5) 0 (0.0) inestimable anxiety

260. Misuse of Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
     September 13, 2024 - prescription stimulants may be associated with cardiovascular problems, mental health disorders (such as anxiety